Indo Count Industries Toekomstige groei
Future criteriumcontroles 3/6
Indo Count Industries zal naar verwachting groeien in winst en omzet met respectievelijk 18.2% en 17.2% per jaar. De winst per aandeel zal naar verwachting groeien met 18.1% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 17% zijn.
Belangrijke informatie
18.2%
Groei van de winst
18.1%
Groei van de winst per aandeel
Luxury winstgroei | 25.7% |
Inkomstengroei | 17.2% |
Toekomstig rendement op eigen vermogen | 17.0% |
Dekking van analisten | Low |
Laatst bijgewerkt | 11 Nov 2024 |
Recente toekomstige groei-updates
Analyst Estimates: Here's What Brokers Think Of Indo Count Industries Limited (NSE:ICIL) After Its First-Quarter Report
Aug 02₹452 - That's What Analysts Think Indo Count Industries Limited (NSE:ICIL) Is Worth After These Results
May 31Indo Count Industries Limited Just Missed EPS By 38%: Here's What Analysts Think Will Happen Next
Feb 01Recent updates
Is There Now An Opportunity In Indo Count Industries Limited (NSE:ICIL)?
Sep 20Here's Why Indo Count Industries (NSE:ICIL) Can Manage Its Debt Responsibly
Aug 22Analyst Estimates: Here's What Brokers Think Of Indo Count Industries Limited (NSE:ICIL) After Its First-Quarter Report
Aug 02Improved Earnings Required Before Indo Count Industries Limited (NSE:ICIL) Stock's 33% Jump Looks Justified
Jul 02Investors Should Be Encouraged By Indo Count Industries' (NSE:ICIL) Returns On Capital
Jun 27News Flash: One Analyst Just Made A Notable Upgrade To Their Indo Count Industries Limited (NSE:ICIL) Forecasts
Jun 02₹452 - That's What Analysts Think Indo Count Industries Limited (NSE:ICIL) Is Worth After These Results
May 31What Does Indo Count Industries Limited's (NSE:ICIL) Share Price Indicate?
May 28Do Indo Count Industries' (NSE:ICIL) Earnings Warrant Your Attention?
Apr 11Investors Should Be Encouraged By Indo Count Industries' (NSE:ICIL) Returns On Capital
Mar 27Indo Count Industries Limited (NSE:ICIL) Held Back By Insufficient Growth Even After Shares Climb 26%
Mar 03Is Now The Time To Look At Buying Indo Count Industries Limited (NSE:ICIL)?
Feb 21Indo Count Industries Limited Just Missed EPS By 38%: Here's What Analysts Think Will Happen Next
Feb 01These 4 Measures Indicate That Indo Count Industries (NSE:ICIL) Is Using Debt Reasonably Well
Nov 21Estimating The Fair Value Of Indo Count Industries Limited (NSE:ICIL)
Jul 25Is It Time To Consider Buying Indo Count Industries Limited (NSE:ICIL)?
May 03Capital Investments At Indo Count Industries (NSE:ICIL) Point To A Promising Future
Dec 26We Think Indo Count Industries Limited's (NSE:ICIL) CEO Compensation Looks Fair
Sep 23Indo Count Industries (NSE:ICIL) Is Reinvesting To Multiply In Value
Aug 27What Does Indo Count Industries Limited's (NSE:ICIL) Share Price Indicate?
Jul 24Why Indo Count Industries Limited (NSE:ICIL) Could Be Worth Watching
Apr 05If You Like EPS Growth Then Check Out Indo Count Industries (NSE:ICIL) Before It's Too Late
Feb 08Does Indo Count Industries (NSE:ICIL) Have A Healthy Balance Sheet?
Dec 20Indo Count Industries (NSE:ICIL) Will Be Hoping To Turn Its Returns On Capital Around
Nov 29Is Now The Time To Put Indo Count Industries (NSE:ICIL) On Your Watchlist?
Oct 28Indo Count Industries (NSE:ICIL) Will Want To Turn Around Its Return Trends
Aug 26Should Weakness in Indo Count Industries Limited's (NSE:ICIL) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Mar 12Three Things You Should Check Before Buying Indo Count Industries Limited (NSE:ICIL) For Its Dividend
Feb 28Is Now The Time To Put Indo Count Industries (NSE:ICIL) On Your Watchlist?
Feb 16Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
3/31/2027 | 57,917 | 4,920 | 2,551 | 3,222 | 1 |
3/31/2026 | 50,225 | 4,277 | 1,778 | 2,894 | 1 |
3/31/2025 | 41,848 | 3,570 | 1,819 | 3,116 | 1 |
9/30/2024 | 37,840 | 3,093 | -2,353 | 0 | N/A |
6/30/2024 | 37,571 | 3,420 | N/A | N/A | N/A |
3/31/2024 | 35,571 | 3,379 | 107 | 1,458 | N/A |
12/31/2023 | 32,709 | 3,407 | N/A | N/A | N/A |
9/30/2023 | 32,148 | 3,203 | 2,763 | 5,235 | N/A |
6/30/2023 | 30,499 | 2,731 | N/A | N/A | N/A |
3/31/2023 | 30,116 | 2,768 | 4,129 | 7,550 | N/A |
12/31/2022 | 28,583 | 2,672 | N/A | N/A | N/A |
9/30/2022 | 29,365 | 3,007 | -1,730 | 734 | N/A |
6/30/2022 | 28,311 | 3,183 | N/A | N/A | N/A |
3/31/2022 | 28,420 | 3,586 | -4,887 | -371 | N/A |
12/31/2021 | 28,787 | 3,312 | N/A | N/A | N/A |
9/30/2021 | 29,263 | 3,531 | -3,377 | -2,562 | N/A |
6/30/2021 | 29,014 | 3,500 | N/A | N/A | N/A |
3/31/2021 | 25,192 | 2,506 | -555 | -197 | N/A |
12/31/2020 | 21,965 | 2,007 | N/A | N/A | N/A |
9/30/2020 | 20,502 | 1,279 | 3,636 | 3,753 | N/A |
6/30/2020 | 19,046 | 570 | N/A | N/A | N/A |
3/31/2020 | 20,801 | 738 | 1,066 | 1,398 | N/A |
12/31/2019 | 21,494 | 614 | N/A | N/A | N/A |
9/30/2019 | 20,403 | 506 | -235 | 310 | N/A |
6/30/2019 | 19,814 | 655 | N/A | N/A | N/A |
3/31/2019 | 19,342 | 602 | 1,548 | 2,145 | N/A |
3/31/2018 | 18,585 | 1,260 | N/A | 423 | N/A |
3/31/2017 | 21,528 | 2,322 | N/A | 2,159 | N/A |
3/31/2016 | 20,627 | 2,514 | N/A | 1,528 | N/A |
3/31/2015 | 17,169 | 1,455 | N/A | 2,362 | N/A |
3/31/2014 | 14,676 | 1,098 | N/A | 342 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei ICIL ( 18.2% per jaar) ligt boven de spaarquote ( 6.7% ).
Winst versus markt: De winst van ICIL ( 18.2% per jaar) zal naar verwachting sneller groeien dan de Indian markt ( 17.9% per jaar).
Hoge groeiwinsten: De winst van ICIL zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van ICIL ( 17.2% per jaar) zal naar verwachting sneller groeien dan de markt Indian ( 10.5% per jaar).
Hoge groei-inkomsten: De omzet van ICIL ( 17.2% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen ICIL zal naar verwachting over 3 jaar laag zijn ( 17 %).